布地奈德联合氨溴索雾化吸入治疗儿童急性喉炎  

Effect of nebulized budesonide combined with ambroxol in treatment of childhood acute laryngitis

作　　者：邓衍圣[1] 吴杰斌[1] 郑刚[1] 黄启凌[1] 

机构地区：[1]安徽省宿州市立医院儿科,234000

出　　处：《蚌埠医学院学报》2011年第6期608-609,共2页Journal of Bengbu Medical College

摘　　要：目的:观察布地奈德联合氨溴索雾化吸入治疗儿童急性喉炎的临床疗效。方法:将71例急性喉炎患儿随机分为治疗组和对照组,对照组39例仅采用地塞米松静脉滴注,治疗组32例采用布地奈德+氨溴索雾化吸入治疗。结果:2组症状和体征消失时间差异均有统计学意义(P<0.01)。治疗组总有效率为96.9%,对照组为74.4%,差异有统计学意义(P<0.05)。结论:儿童急性喉炎采用布地奈德联合氨溴索雾化吸入治疗比地塞米松静脉注射见效快,疗效好,不良反应少。Objective： To observe the clinical curative effect and safety of aerosol inhaled budesonide combined with ambroxol for children with acute laryngitis. Methods： Seventy-one children with acute laryngitis were randomly divided into treatment group and control group. The children in treatment group （32 cases） were cured with aerosol inhalation of budesonide and ambroxol with air compress pump nebuliser,and others in control group （39 cases） were treated with intravenous drip of dexamethasone. Results：The symptoms and signs dispeared significantly faster in the treatment group when compared with that of control group（P 〈 0.01 ）. The total effective rate of the treatment group was 96.9%, the control group was 74.4% （P 〈 0.05 ）. Conclusions： The treatment of aerosol inhaled of budesonide combined with ambroxol for children with acute laryngitis has greater efficacy and fewer side effects.

关 键 词：喉炎 布地奈德 氨溴索 地塞米松 

分 类 号：R767.11[医药卫生—耳鼻咽喉科]